Article Information
History
- July 5, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Yinhai Wang1,
- Ramzi Ajjan2,
- Adrian Freeman3,
- Paul Stewart4,5,
- Francesco Del Galdo5,6 and
- Ana Tiganescu2,*
- 1Data Sciences & Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
- 2Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK
- 3Emerging Innovations Unit, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
- 4Faculty of Medicine and Health, University of Leeds, Leeds, UK
- 5NIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK
- 6Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK
- ↵*Corresponding author: Ana Tiganescu, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, LIGHT Building, Clarendon Way University of Leeds, LS2 9JT, UK, 0113 34 38336, a.tiganescu{at}leeds.ac.uk